CE · Celanese Corp

Track CE — free

$44.87 +0.17 (+0.38%) At close · Aug 27

Market Cap

$4.90B

109.75M

Up next

Next earnings call

Nov 2, 2026 Est · unconfirmed · in 9 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed Aug 5, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Ask ALVIS about this →

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol High

Market backdrop VIX 14.5 · calm Equity put/call 0.39

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg −11%

below

Price vs 50-day avg −3%

below

RSI (14) 47

neutral

MACD trend Positive

52-week position 28%

mid-range

Momentum

relative strength

Weak

1-month return 0%

trailing

6-month return −9%

trailing

YTD return +6%

this year

Relative strength −24%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $46 › 200d $51 — 200d above 50d

Institutional flow Distributing

-3% holders QoQ · +85 funds added

Insider flow Accumulating

Net +$230.1K over 90 days · 0% sells

Short interest Falling

6.22% of float · ▼ -20.2% MoM · 2.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

462 holders — mid 3-yr range

Squeeze score 56

elevated · 0–100

Fundamentals

Strong

Revenue growth −7%

Y/Y

Gross margin 20%

contracting

EPS growth +25%

Y/Y

Free cash flow $803.0M

Buyback $6.9B

authorized

Balance sheet $13.1B

net debt

Quant / Vol

risk profile

High

Volatility 54%

annualized · 1-yr

Max drawdown −38%

past year

ATR 4.0%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Aug 4, 2026

third quarter

Adjusted earnings per share Non-GAAP $1.35 – $1.75

full year

Free cash flow Non-GAAP $700M – $800M

Prior guidance period ended · from the 8-K filed May 5, 2026

Adjusted earnings per share · second quarter 2026 $2.00 – $2.40

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral

1 · 4 · 1

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−11% Bearish

Price vs 50-day avg

−3% Neutral

RSI (14)

47 Neutral

MACD trend

Positive Bullish

52-week position

28% Neutral

Market signals — smart money & positioning

Bullish · 2 of 6

Trend (MA cross) No cross

50d $46 › 200d $51 — 200d above 50d

Institutional flow Distributing

-3% holders QoQ · +85 funds added

Insider flow Accumulating

Net +$230.1K over 90 days · 0% sells

Short interest Falling

6.22% of float · ▼ -20.2% MoM · 2.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

462 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $36 Now $45 · 28% Range high $69

vs 200-day avg -11% vs 50-day avg -3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted EBIT non-GAAP	$470M	Three Months Ended June 30, 2026	—

GAAP → non-GAAP reconciliation GAAP Net earnings (loss) attributable to Celanese Corporation $125M +$2M (Earnings) loss from discontinued operations -$10M Interest income +$186M Interest expense +$0M Refinancing expense +$11M Income tax provision (benefit) +$156M Certain Items attributable to Celanese Corporation (Table 8) = Adjusted EBIT $470M
Adjusted EBIT - Acetyl Chain non-GAAP	$321M	Three Months Ended June 30, 2026	—

Adjusted EBIT - Engineered Materials non-GAAP	$234M	Three Months Ended June 30, 2026	—

Adjusted EBIT margin non-GAAP	17.1%	Q2 '26	—

Free cash flow non-GAAP	$140M	Three Months Ended June 30, 2026	—

GAAP → non-GAAP reconciliation GAAP Net cash provided by (used in) operating activities 209M -62M Capital expenditures on property, plant and equipment -7M Contributions from/(Distributions) to NCI = Free cash flow 140M
Free cash flow as % of Net sales non-GAAP	5.1%	Q2 '26	—

Operating EBITDA non-GAAP	$649M	Three Months Ended June 30, 2026	—

GAAP → non-GAAP reconciliation GAAP Adjusted EBIT $470M +$179M Depreciation and amortization expense = Operating EBITDA $649M
Operating EBITDA margin non-GAAP	23.6%	Q2 '26	—

Return on invested capital (adjusted) non-GAAP	6.2%	2025	—
Net debt non-GAAP	$10.8B	Q1 '26	—

Operating EBITDA - Engineered Materials non-GAAP	$324M	Q1 '26	—
Adjusted earnings (loss) from continuing operations non-GAAP	$74M	Q4 '25	—
GAAP → non-GAAP reconciliation GAAP Adjusted earnings (loss) from continuing operations before tax $80M -$6M Income tax (provision) benefit on adjusted earnings = Adjusted earnings (loss) from continuing operations $74M
Adjusted earnings per share non-GAAP	$3.98	2025	—
Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital non-GAAP	-6.8%	2025	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Chemicals — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
CE Celanese Corp this stock	$4.90B	+6.1%	-7.1%	—	6.2%
SHECF Shin-Etsu Chemical Co., Ltd.	$69.72B	+15.7%	—	—	0.2%
DOW Dow Inc.	$21.82B	+29.7%	-7.0%	—	5.2%
NPXYY Nippon Sanso Holdings Corporation/ADR	$15.11B	+20.0%	—	—	0.0%
MEOH Methanex Corp	$4.51B	+46.9%	—	—	2.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

462

% held: 113.4%
Net QoQ: +14.5M sh
Top holder: Dodge & Cox

Held Float

View

Held by Funds

Fund positions

410

View

Short & Settlement

Short Interest Falling

Shares short

6.8M

Days to cover: 2.9d
Change: -1.7M sh

View

Short Volume

Short vol %

55%

As of: Aug 27, 2026

Short Total

View

Fails to Deliver

FTD shares

53.6K

Value: $2.5M
As of: Jul 24, 2026

View

Off-Exchange

Off-exchange %

38.1%

Week of: Jul 20, 2026

Off-exch Lit

View

Smart Money

Insider Trades Cluster buy

Net (90d)

+$230.1K

Buyers / Sellers: 3 / 0

Buyers Sellers

View

Congressional Trades Sell

Member

Kathy Manning

Amount: $1.0K–$15.0K
Traded: Aug 3, 2022

View

Financials

Revenue (FY)

$9.5B

Net income (FY): $-1.2B
EPS diluted: $-10.64

View

Buybacks

Authorized

$6.9B

View

Filings

SEC Filings

Latest

10-Q

Filed: Aug 5, 2026
This year: 16

View

Proposed Sales

Value

$1.4M

Shares: 27.9K
Filed: May 9, 2025

View

Earnings & Events

Earnings Calls

Last call

Aug 5, 2026

View

Performance

	5D	20D	120D	MTD	YTD
CE	-4.5%	+0.1%	-9.0%	+0.3%	+6.1%
SPY	+1.1%	+4.0%	+14.7%	+3.2%	+13.1%
vs SPY	-5.6%	-3.8%	-23.7%	-2.9%	-7.0%

Capital returns

Latest dividend

$0.03 / share · ex Jul 28, 2026

Cut 95.7%

Paid (TTM)

$0.12 / share · 4 payouts

Dividend yield (TTM, derived)

0.27%

Buyback program · as of Jun 30, 2026

Authorized

$6.87B

Spent (derived)

—

Remaining

—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1306830 CUSIP 150870103 13F (30d) 358 filings 354 filers Visit website Investor relations

CE · Celanese Corp

Price & Indicators

Up next

AI Brief

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns